Safilo Group S.p.A. (SAFLF)
USD 0.98
(0.0%)
USD 0.98
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 228.99 Million EUR | -11.58% |
| 2022 | 258.98 Million EUR | 10.47% |
| 2021 | 234.43 Million EUR | 18.83% |
| 2020 | 197.28 Million EUR | -16.33% |
| 2019 | 235.8 Million EUR | -0.8% |
| 2018 | 237.71 Million EUR | -7.76% |
| 2017 | 257.71 Million EUR | -5.53% |
| 2016 | 272.81 Million EUR | 7.37% |
| 2015 | 254.07 Million EUR | 2.61% |
| 2014 | 247.61 Million EUR | 16.37% |
| 2013 | 212.78 Million EUR | 2.48% |
| 2012 | 207.63 Million EUR | -5.5% |
| 2011 | 219.73 Million EUR | -0.32% |
| 2010 | 220.44 Million EUR | 5.79% |
| 2009 | 208.37 Million EUR | -23.42% |
| 2008 | 272.1 Million EUR | -0.8% |
| 2007 | 274.28 Million EUR | 1.0% |
| 2006 | 271.57 Million EUR | 30.06% |
| 2005 | 208.8 Million EUR | 8.64% |
| 2004 | 192.19 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 197.4 Million EUR | 0.0% |
| 2024 Q1 | 197.4 Million EUR | -13.79% |
| 2023 Q4 | 228.99 Million EUR | 0.0% |
| 2023 Q1 | 230.71 Million EUR | -10.91% |
| 2023 Q3 | 228.99 Million EUR | -0.75% |
| 2023 Q2 | 230.71 Million EUR | 0.0% |
| 2023 FY | 228.99 Million EUR | -11.58% |
| 2022 Q3 | 258.98 Million EUR | 2.47% |
| 2022 Q4 | 258.98 Million EUR | 0.0% |
| 2022 FY | 258.98 Million EUR | 10.47% |
| 2022 Q1 | 252.72 Million EUR | 7.81% |
| 2022 Q2 | 252.72 Million EUR | 0.0% |
| 2021 Q2 | 195.06 Million EUR | 0.0% |
| 2021 Q3 | 234.43 Million EUR | 20.18% |
| 2021 Q1 | 195.06 Million EUR | -1.13% |
| 2021 Q4 | 234.43 Million EUR | 0.0% |
| 2021 FY | 234.43 Million EUR | 18.83% |
| 2020 Q1 | 228.41 Million EUR | -3.13% |
| 2020 Q3 | 197.28 Million EUR | -13.63% |
| 2020 Q2 | 228.41 Million EUR | 0.0% |
| 2020 FY | 197.28 Million EUR | -16.33% |
| 2020 Q4 | 197.28 Million EUR | 0.0% |
| 2019 Q1 | 218.08 Million EUR | -8.25% |
| 2019 Q3 | 235.8 Million EUR | 8.12% |
| 2019 Q2 | 218.08 Million EUR | 0.0% |
| 2019 FY | 235.8 Million EUR | -0.8% |
| 2019 Q4 | 235.8 Million EUR | 0.0% |
| 2018 Q3 | 237.71 Million EUR | -3.07% |
| 2018 Q1 | 245.23 Million EUR | -4.84% |
| 2018 FY | 237.71 Million EUR | -7.76% |
| 2018 Q4 | 237.71 Million EUR | 0.0% |
| 2018 Q2 | 245.23 Million EUR | 0.0% |
| 2017 Q2 | 271.07 Million EUR | 0.0% |
| 2017 Q1 | 271.07 Million EUR | -0.64% |
| 2017 FY | 257.71 Million EUR | -5.53% |
| 2017 Q4 | 257.71 Million EUR | 0.0% |
| 2017 Q3 | 257.71 Million EUR | -4.93% |
| 2016 Q1 | 268.62 Million EUR | 5.72% |
| 2016 FY | 272.81 Million EUR | 7.37% |
| 2016 Q4 | 272.81 Million EUR | 0.0% |
| 2016 Q3 | 272.81 Million EUR | 1.56% |
| 2016 Q2 | 268.62 Million EUR | 0.0% |
| 2015 Q3 | 255.1 Million EUR | 3.06% |
| 2015 Q4 | 254.07 Million EUR | -0.4% |
| 2015 Q2 | 247.52 Million EUR | -4.46% |
| 2015 FY | 254.07 Million EUR | 2.61% |
| 2015 Q1 | 259.08 Million EUR | 4.63% |
| 2014 Q3 | 256.26 Million EUR | 11.14% |
| 2014 Q4 | 247.61 Million EUR | -3.38% |
| 2014 Q1 | 213.82 Million EUR | 0.49% |
| 2014 FY | 247.61 Million EUR | 16.37% |
| 2014 Q2 | 230.58 Million EUR | 7.84% |
| 2013 Q4 | 212.78 Million EUR | 4.23% |
| 2013 FY | 212.78 Million EUR | 2.48% |
| 2013 Q3 | 204.14 Million EUR | 5.53% |
| 2013 Q2 | 193.44 Million EUR | -0.27% |
| 2013 Q1 | 193.97 Million EUR | -6.58% |
| 2012 Q2 | 216.6 Million EUR | -0.19% |
| 2012 Q4 | 207.63 Million EUR | -5.68% |
| 2012 FY | 207.63 Million EUR | -5.5% |
| 2012 Q1 | 217.02 Million EUR | -1.24% |
| 2012 Q3 | 220.15 Million EUR | 1.64% |
| 2011 FY | 219.73 Million EUR | -0.32% |
| 2011 Q1 | 205.06 Million EUR | -6.98% |
| 2011 Q2 | 192.13 Million EUR | -6.31% |
| 2011 Q3 | 211.81 Million EUR | 10.25% |
| 2011 Q4 | 219.73 Million EUR | 3.74% |
| 2010 FY | 220.44 Million EUR | 5.79% |
| 2010 Q1 | 200.04 Million EUR | -4.0% |
| 2010 Q2 | 195.73 Million EUR | -2.15% |
| 2010 Q4 | 220.44 Million EUR | 10.44% |
| 2010 Q3 | 199.6 Million EUR | 1.97% |
| 2009 Q4 | 208.37 Million EUR | 0.0% |
| 2009 FY | 208.37 Million EUR | -23.42% |
| 2008 FY | 272.1 Million EUR | -0.8% |
| 2007 FY | 274.28 Million EUR | 1.0% |
| 2006 FY | 271.57 Million EUR | 30.06% |
| 2005 FY | 208.8 Million EUR | 8.64% |
| 2004 FY | 192.19 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | -171007.159% |
| Ansell Limited | 457.04 Million USD | 49.897% |
| Ansell Limited | 457.9 Million USD | 49.991% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | -428.413% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -820950.556% |
| Psykey, Inc. | 49.94 Thousand USD | -458432.239% |
| ConvaTec Group Plc | 395.54 Million USD | 42.107% |
| ConvaTec Group Plc | 396.1 Million USD | 42.189% |
| Encision Inc. | 1.4 Million USD | -16229.23% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 2463958.403% |
| LifePoint, Inc. | 2.3 Million USD | -9815.851% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | -9429.38% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | -51825.397% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -249122.916% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | -23451.645% |
| SmileDirectClub, Inc. | 49.87 Million USD | -359.139% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 34.899% |
| SheerVision, Inc. | 339.66 Thousand USD | -67317.116% |
| United Health Products, Inc. | 33.59 Thousand USD | -681461.402% |
| Vasamed, Inc. | 449.02 Thousand USD | -50897.043% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -2676591.993% |
| Yubo International Biotech Limited | 322.17 Thousand USD | -70977.03% |